ANSERINE
UNII HDQ4N37UGV

Substance Identification & Data

This profile provides standardized clinical and technical data for Anserine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HDQ4N37UGV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 584-85-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

HDQ4N37UGV

CAS Registry Number

584-85-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANSERINE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

HDQ4N37UGV

The specific atomic composition represented as a molecular structure string.

InChIKey

C10H16N4O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MYYIAHXIVFADCU-QMMMGPOBSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C118877

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

112072

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1(cncc1C[C@@H](C(=O)O)NC(CCN)=O)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anserine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.